Deal Watch: Pfizer Licenses Cellectis' TALENted CAR-T Candidate
Executive Summary
Array partners with Pierre Fabre to develop and commercialize the MEK and BRAF inhibitors it got from Novartis earlier this year. Astellas buys ophthalmology company Ocata, while divesting dermatology portfolio to Leo Pharma.